Rs 2,700 cancer drug selling for Rs 27,000: Supreme Court calls it ‘daylight robbery’
The Supreme Court has described the steep markup on essential cancer medicines as “daylight robbery” after being told that a drug available to retailers for Rs 2,700 carried a maximum retail price of Rs 27,000. A bench of Justices Vikram Nath and Sandeep Mehta questioned how patients could be charged 10 times the procurement price…
